Longitudinal association between cognitive depressive symptoms and D-dimer levels in patients following acute myocardial infarction.
coronary heart disease, coagulation
cortisol
psychological stress
Journal
Clinical cardiology
ISSN: 1932-8737
Titre abrégé: Clin Cardiol
Pays: United States
ID NLM: 7903272
Informations de publication
Date de publication:
Sep 2021
Sep 2021
Historique:
revised:
22
06
2021
received:
27
04
2021
accepted:
29
06
2021
pubmed:
8
7
2021
medline:
16
10
2021
entrez:
7
7
2021
Statut:
ppublish
Résumé
A prothrombotic tendency could partially explain the poor prognosis of patients with coronary heart disease and depression. We hypothesized that cognitive depressive symptoms are positively associated with the coagulation activation marker D-dimer throughout the first year after myocardial infarction (MI). Patients with acute MI (mean age 60 years, 85% men) were investigated at hospital admission (n = 190), 3 months (n = 154) and 12 months (n = 106). Random linear mixed regression models were used to evaluate the relation between cognitive depressive symptoms, assessed with the Beck depression inventory (BDI), and changes in plasma D-dimer levels. Demographics, cardiac disease severity, medical comorbidity, depression history, medication, health behaviors, and stress hormones were considered for analyses. The prevalence of clinical depressive symptoms (13-item BDI score ≥ 6) was 13.2% at admission and stable across time. Both continuous (p < .05) and categorical (p < .010) cognitive depressive symptoms were related to higher D-dimer levels over time, independent of covariates. Indicating clinical relevance, D-dimer was 73 ng/ml higher in patients with a BDI score ≥ 6 versus those with a score < 6. There was a cognitive depressive symptom-by-cortisol interaction (p < .05) with a positive association between cognitive depressive symptoms and D-dimer when cortisol levels were high (p < .010), but not when cortisol levels were low (p > .05). Fluctuations (up and down) of cognitive depressive symptoms and D-dimer from one investigation to the next showed also significant associations (p < .05). Cognitive depressive symptoms were independently associated with hypercoagulability in patients up to 1 year after MI. Hypothalamic-pituitary-adrenal axis could potentially modify this effect.
Sections du résumé
BACKGROUND
BACKGROUND
A prothrombotic tendency could partially explain the poor prognosis of patients with coronary heart disease and depression. We hypothesized that cognitive depressive symptoms are positively associated with the coagulation activation marker D-dimer throughout the first year after myocardial infarction (MI).
METHODS
METHODS
Patients with acute MI (mean age 60 years, 85% men) were investigated at hospital admission (n = 190), 3 months (n = 154) and 12 months (n = 106). Random linear mixed regression models were used to evaluate the relation between cognitive depressive symptoms, assessed with the Beck depression inventory (BDI), and changes in plasma D-dimer levels. Demographics, cardiac disease severity, medical comorbidity, depression history, medication, health behaviors, and stress hormones were considered for analyses.
RESULTS
RESULTS
The prevalence of clinical depressive symptoms (13-item BDI score ≥ 6) was 13.2% at admission and stable across time. Both continuous (p < .05) and categorical (p < .010) cognitive depressive symptoms were related to higher D-dimer levels over time, independent of covariates. Indicating clinical relevance, D-dimer was 73 ng/ml higher in patients with a BDI score ≥ 6 versus those with a score < 6. There was a cognitive depressive symptom-by-cortisol interaction (p < .05) with a positive association between cognitive depressive symptoms and D-dimer when cortisol levels were high (p < .010), but not when cortisol levels were low (p > .05). Fluctuations (up and down) of cognitive depressive symptoms and D-dimer from one investigation to the next showed also significant associations (p < .05).
CONCLUSIONS
CONCLUSIONS
Cognitive depressive symptoms were independently associated with hypercoagulability in patients up to 1 year after MI. Hypothalamic-pituitary-adrenal axis could potentially modify this effect.
Identifiants
pubmed: 34231917
doi: 10.1002/clc.23689
pmc: PMC8428069
doi:
Substances chimiques
Fibrin Fibrinogen Degradation Products
0
fibrin fragment D
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1316-1325Subventions
Organisme : Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
ID : 140960
Informations de copyright
© 2021 The Authors. Clinical Cardiology published by Wiley Periodicals LLC.
Références
Psychother Psychosom. 2021;90(1):11-27
pubmed: 32799204
Am J Cardiol. 2005 Dec 1;96(11):1512-6
pubmed: 16310432
Thromb Haemost. 2014 Nov;112(5):860-7
pubmed: 25231258
Clin Chem Lab Med. 2009;47(8):945-51
pubmed: 19548843
J Gen Intern Med. 2006 Jan;21(1):30-8
pubmed: 16423120
Blood Coagul Fibrinolysis. 2013 Oct;24(7):704-10
pubmed: 23571687
J Affect Disord. 2020 Apr 1;266:158-164
pubmed: 32056871
Clin Cardiol. 2003 Apr;26(4):164-8
pubmed: 12708621
Crit Rev Clin Lab Sci. 2018 Dec;55(8):548-577
pubmed: 30694079
Semin Vasc Med. 2005 Nov;5(4):387-98
pubmed: 16302161
Circulation. 2002 Mar 5;105(9):1049-53
pubmed: 11877353
PLoS One. 2013;8(2):e55175
pubmed: 23408959
J Thromb Haemost. 2009 Apr;7(4):573-81
pubmed: 19192119
Semin Thromb Hemost. 2013 Nov;39(8):902-12
pubmed: 24114007
J Am Coll Cardiol. 2014 Jul 8;64(1):100-10
pubmed: 24998134
Alcohol Clin Exp Res. 1997 Oct;21(7):1285-93
pubmed: 9347091
J Pediatr Psychol. 2002 Jan-Feb;27(1):87-96
pubmed: 11726683
Arterioscler Thromb Vasc Biol. 2006 Dec;26(12):2793-9
pubmed: 17023678
Clin Cardiol. 2021 Sep;44(9):1316-1325
pubmed: 34231917
Psychosom Med. 2009 Apr;71(3):253-9
pubmed: 19251868
Int J Mol Sci. 2020 Nov 21;21(22):
pubmed: 33233416
Front Psychiatry. 2021 May 14;12:621284
pubmed: 34108894
Medicine (Baltimore). 2019 Feb;98(8):e14596
pubmed: 30813183
Gen Hosp Psychiatry. 2011 May-Jun;33(3):203-16
pubmed: 21601716
Nat Rev Cardiol. 2017 Mar;14(3):145-155
pubmed: 27853162
Eur J Cardiovasc Prev Rehabil. 2007 Dec;14(6):782-7
pubmed: 18043299
J Psychosom Res. 2017 Aug;99:162-168
pubmed: 28712423
Eur Heart J. 2020 May 1;41(17):1687-1696
pubmed: 30698764
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Cardiology. 2015;131(2):80-5
pubmed: 25870996
Semin Thromb Hemost. 2013 Nov;39(8):876-80
pubmed: 24108468
Circulation. 1999 May 18;99(19):2517-22
pubmed: 10330382
BMC Med. 2013 May 15;11:130
pubmed: 23676144
Circulation. 2004 Apr 27;109(16):1955-9
pubmed: 15051634
Circulation. 2018 Aug 14;138(7):712-723
pubmed: 29367425
ISRN Cardiol. 2012;2012:743813
pubmed: 23227360
BMC Psychiatry. 2014 Dec 24;14:371
pubmed: 25540022
Psychother Psychosom. 2018;87(2):75-84
pubmed: 29462823
Trials. 2013 Oct 11;14:329
pubmed: 24119487